4200 studies found for:    bind
Show Display Options
Rank Status Study
1 Completed A Phase 2 Study to Determine the Safety and Efficacy of BIND-014 (Docetaxel Nanoparticles for Injectable Suspension), Administered to Patients With Metastatic Castration-Resistant Prostate Cancer
Conditions: CRPC;   Prostate Cancer
Intervention: Drug: BIND-014
2 Completed A Study of BIND-014 Given to Patients With Advanced or Metastatic Cancer
Conditions: Metastatic Cancer;   Cancer;   Solid Tumors
Intervention: Drug: BIND-014
3 Completed A Phase 2 Study to Determine the Safety and Efficacy of BIND-014 (Docetaxel Nanoparticles for Injectable Suspension) as Second-line Therapy to Patients With Non-Small Cell Lung Cancer
Condition: Non-small Cell Lung Cancer
Intervention: Drug: BIND-014
4 Completed A Study of BIND-014 (Docetaxel Nanoparticles for Injectable Suspension) as Second-line Therapy for Patients With KRAS Positive or Squamous Cell Non-Small Cell Lung Cancer
Conditions: KRAS Positive Patients With Non-small Cell Lung Cancer;   Squamous Cell Non-small Cell Lung Cancer
Intervention: Drug: BIND-014 (Docetaxel Nanoparticles for Injectable Suspension)
5 Terminated A Study of BIND-014 in Patients With Urothelial Carcinoma, Cholangiocarcinoma, Cervical Cancer and Squamous Cell Carcinoma of the Head and Neck
Conditions: Urothelial Carcinoma;   Cholangiocarcinoma;   Cervical Cancer;   Squamous Cell Carcinoma of Head and Neck
Intervention: Drug: BIND-014 (docetaxel nanoparticles for injectable suspension)
6 Recruiting Clinical Study of Albumin-bound Paclitaxel Plus Nedaplatin in Cervical Cancer
Condition: Uterine Cervical Cancer
Intervention: Drug: albumin-bound paclitaxel plus nedaplatin
7 Recruiting Phase II Study of Albumin Bound Paclitaxel With 5-FU and CF as Second Line in Taxanes Naive Advanced Gastric Cancer
Condition: Gastric Caner
Interventions: Drug: Albumin Bound Paclitaxel;   Drug: 5-FU
8 Active, not recruiting Weekly Nanoparticle Albumin-Bound Paclitaxel (Abraxane) + Weekly Cetuximab + Radiation Therapy (IMRT, Intensity-Modulated Radiation Therapy) in Patients With Stage III-IVB Head and Neck Squamous Cell Carcinoma (HNSCC)
Condition: HEAD & NECK Cancer
Intervention: Other: Cetuximab, IMRT, Albumin-bound paclitaxel (Abraxane®)
9 Completed Wheelchair-bound Senior Elastic Band (WSEB) Exercise Program for the Demented Seniors
Condition: Dementia
Intervention: Other: Wheelchair-bound Senior Elastic Band exercise program (WSEB)
10 Recruiting Albumin-Bound Paclitaxel and Gemcitabine in Patients With Untreated Stage IV or Recurrent Squamous Cell Lung Cancers
Conditions: Lung Cancer;   Untreated Stage IV or Recurrent Squamous Cell Lung Cancers
Interventions: Drug: albumin-bound paclitaxel;   Drug: gemcitabine
11 Withdrawn Neoadjuvant Chemotherapy of Nanoparticle Albumin-bound Paclitaxel in Squamous Cell Carcinoma of Esophagus
Condition: Squamous Cell Carcinoma of Esophagus
Intervention: Drug: nanoparticle albumin-bound paclitaxel
12 Unknown  Neoadjuvant Chemotherapy of Nanoparticle Albumin-bound Paclitaxel in Lung Cancer
Condition: Non Small Cell Lung Cancer
Intervention: Drug: nanoparticle albumin-bound paclitaxel
13 Recruiting Neoadjuvant Chemotherapy of Nanoparticle Albumin-bound Paclitaxel/Carboplatin vs. Paclitaxel /Carboplatin in Stage Ⅱ B and IIIA Squamous Cell Carcinoma of the Lung
Condition: Non-small Cell Lung Cancer
Intervention: Drug: nanoparticle albumin-bound paclitaxel/carboplatin
14 Recruiting Albumin Bound Paclitaxel Plus S-1 as the First Line Chemotherapy in Advanced or Recurrent Gastric Cancer
Condition: Gastric Cancer
Interventions: Drug: Albumin Bound Paclitaxel;   Drug: S-1
15 Completed Diagnostic Value of Heart-Fatty Acid Binding Protein and Ischemia Modified Albumin as Biochemical Markers on Non ST Segment Elevation Acute Coronary Syndrome at the Emergency Room.
Condition: Acute Coronary Syndrome
Intervention: Other: Measure of Initial heart fatty acid binding protein and ischemia modified albumin
16 Completed The Value of HBA in the Evaluation of Idiopathic Infertility
Condition: Infertility
Intervention: Other: HBA binding assay
17 Unknown  Genome Wide SNP Array-based Approach to Detect Micro-cytogenetic Lesions and KIT Mutation to Improve Treatment Outcomes in Patients With Core-binding Factor Positive Acute Myeloid Leukemia
Condition: Myeloid Leukemia
Intervention:
18 Recruiting Evaluation of the Heparin Binding Protein Levels in Sepsis
Conditions: Sepsis;   Infection;   Septic Shock
Intervention: Other: HBP lab test
19 Completed Determining Prevalence of Acute Bilirubin Encephalopathy in Developing Countries
Conditions: Demonstrate BIND II Score of >=5, is Valid for Detecting Moderate to Severe ABE in Neonates <14 Days Old.;   Demonstrate Community-BIND Instrument, a Modified BIND II, is a Valid and Reliable Tool for Detecting ABE.;   Demonstrate That Community-BIND Can be Used for Acquiring Population-based Prevalence of ABE in the Community.
Intervention: Other: Bilirubin Induced Neurologic Dysfunction II score
20 Completed TNF-Bound Colloidal Gold in Treating Patients With Advanced Solid Tumors
Condition: Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Biological: colloidal gold-bound tumor necrosis factor;   Other: pharmacological study

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years